Cargando…
Impact of pharmacist intervention on anticoagulation management and risk for potential COVID-19 exposure during the COVID-19 pandemic
INTRODUCTION: Patients taking warfarin require frequent international normalized ratio (INR) monitoring in healthcare settings, putting them at increased risk of Coronavirus disease 2019 (COVID-19) exposure during the pandemic. Thus, strategies to limit in-person visits to healthcare facilities were...
Autores principales: | Lee, Lindsey C., Farwig, Phillip, Kirk, Lauren, Mitchell, Virginia D., Sabatino, Jennifer A., Barnes, Kelli D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288238/ https://www.ncbi.nlm.nih.gov/pubmed/35868151 http://dx.doi.org/10.1016/j.thromres.2022.07.004 |
Ejemplares similares
-
Anticoagulation and bleeding risk in patients with COVID-19
por: Musoke, Nancy, et al.
Publicado: (2020) -
The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists()
por: Visser, Chantal, et al.
Publicado: (2023) -
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2020) -
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021) -
Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes
por: Filippi, Lucia, et al.
Publicado: (2023)